Page 13 - Andreaf Wainer News Today

Financial Counselors Inc. lifted its position in Abbott Laboratories (NYSE:ABT – Free Report) by 1.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 52,960 shares of the healthcare product maker’s stock after purchasing an additional 964 shares during the quarter. […]

Arbor Investment Advisors LLC lowered its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 15.4% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 1,922 shares of the healthcare product maker’s stock after selling 351 shares during the period. Arbor Investment Advisors LLC’s […]

Luts & Greenleigh Group Inc. trimmed its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 1.7% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 13,765 shares of the healthcare product maker’s stock after selling 244 shares during the period. Abbott Laboratories comprises […]

Sequoia Financial Advisors LLC increased its position in Abbott Laboratories (NYSE:ABT – Free Report) by 408.4% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 152,403 shares of the healthcare product maker’s stock after purchasing an additional 122,428 shares during […]

Aull & Monroe Investment Management Corp trimmed its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 2.8% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 19,551 shares of the healthcare product maker’s stock after selling 553 shares during the quarter. […]

Brown Financial Advisory acquired a new stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 1,904 shares of the healthcare product maker’s stock, valued at approximately $210,000. A number of other […]

Fortune Financial Advisors LLC trimmed its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 7.0% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 11,321 shares of the healthcare product maker’s stock after selling 849 shares during the quarter. Fortune Financial […]

Dearborn Partners LLC decreased its position in Abbott Laboratories (NYSE:ABT – Free Report) by 1.5% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 362,774 shares of the healthcare product maker’s stock after selling 5,475 shares during the period. Dearborn Partners LLC’s holdings […]

Moseley Investment Management Inc. bought a new stake in Abbott Laboratories (NYSE:ABT – Free Report) in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor bought 1,946 shares of the healthcare product maker’s stock, valued at approximately $214,000. A number of other large investors have also recently […]

Aull & Monroe Investment Management Corp trimmed its position in Abbott Laboratories (NYSE:ABT – Free Report) by 2.8% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 19,551 shares of the healthcare product maker’s stock after selling 553 shares during the quarter. Aull & […]